VDC test kit slider
VDC test kit slider

Experimental therapy increases length of survival in elderly AML patients

Posted on: July 3, 2013   by  Brant Cebulla


A study recently published in Plos One reports that vitamin D and the drug deferasirox may help increase length of survival in elderly patients with acute myeloid leukemia (AML).

The researchers, led by Dr Etienne Paubelle of Paris Descartes University, administered deferasirox (1-2 g/day) and 100,000 IU of 25(OH)D/week in 17 patients with AML.

You must be a paid member to read the rest of this post. Please login or register now.

Test Your Vitamin D Levels at Home!

Our in-home Vitamin D Test Kit is easy, affordable, and an accurate way to find out your Vitamin D status.

order NOW

We need your help!

We're spreading awareness on Vitamin D Deficiency
Donate NOW
Latest Articles
Can vitamin D supplementation increase your risk of adverse effects? This study suggests otherwise.

A meta-analysis of RCTs discovered that vitamin D supplementation did not increase the risk of noncalcemic adverse effects compared to a placebo.

Weekly Newsletter